Due to the lack of real-world case series, our observations need to be confirmed in larger registries to ascertain the causal relationship and the pathophysiological mechanism encompassing hypertension after myosin inhibitor initiation in severe obstructive HCM. The gene discussed is MYH14; the disease is hypertensive disorder.